SIGA Technologies Inc Stock News

Healthcare stocks haven't moved since the April lows. As contrarian investors, this neglect piques our interest.

SIGA's investment thesis is overwhelmingly tied to the renewal of the BARDA contract, which remains highly uncertain due to political and budgetary risks. Recent revenue growth and a strong balance sheet are positives, but the company faces label risk in the EU and heavy reliance on U.S. government funding. Potential catalysts include TPOXX label expansion for post-exposure prophylaxis and a ne...

SIGA (SIGA) Q2 Revenue Soars 272%

SIGA Technologies, Inc. (NASDAQ:SIGA ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Daniel J. Luckshire - Executive VP, CFO & Secretary Diem Nguyen - CEO & Director Conference Call Participants Jyoti Prakash - Edison Investment Research Limited Operator Welcome to the SIGA Business Update Call.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and six months ended June 30, 2025.

The healthcare sector has long been a favorite for income investors -- and for good reason. Many healthcare stocks offer attractive dividend yields.

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.

SIGA Technologies, Inc. (NASDAQ:SIGA ) Q1 2025 Results Conference Call May 8, 2025 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Dan Luckshire - Executive Vice President & Chief Financial Officer Conference Call Participants Jyoti Prakash - Edison Group Operator Good afternoon. Welcome to SIGA Technologies business update call.